EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Silico Design of Pyrimidine Derivatives as Potential α-Glucosidase Inhibitors: QSAR, Molecular Docking, ADMET, and Molecular Dynamics Studies

Oussama Abchir iD, Bouchra Rossafi, Amal Bouribab, Bouchra Es-Sounni iD, Rodouan Touti iD, Imane Yamari iD, Abdelouahid Samadi iD, Samir Chtita iD

International Journal of Molecular Sciences · 24.06.2026 · 27 (13) · 5696

DOI: 10.3390/ijms27135696 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.06.2026. Verfasst von Oussama Abchir und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Analytical and Molecular Chemistry, Hassan II University of Casablanca, Casablanca 20360, Morocco. Hauptthemen laut MEDLINE: Glycoside Hydrolase Inhibitors, Molecular Docking Simulation, Pyrimidines, alpha-Glucosidases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Sharjah, United Arab Emirates University, Zayed Bin Sultan Center for Health Sciences and UAEU—University of Sharjah.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus remains a major metabolic disorder requiring the development of new and effective α-glucosidase inhibitors. The present study aimed to identify, design, and optimize novel 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-α]pyrimidine derivatives with promising inhibitory activity against the α-glucosidase enzyme using a comprehensive in silico strategy. Approximately 300 molecular descriptors were calculated to characterize a dataset of 32 compounds (Peytam et al.) and to investigate the structural factors governing their biological activity. Based on these descriptors, a multiple linear regression model was developed to predict the inhibitory activities of the compounds against alpha-glucosidase. The developed model demonstrated satisfactory predictive performance and was internally and externally validated to ensure its accuracy, robustness, and reproducibility. In addition, the applicability domain analysis confirmed the reliability of the predictions. Using the validated QSAR model, seven new derivatives were designed with predicted pIC50 values exceeding the maximum activity of the parent compounds. The leverage analysis demonstrated that all newly designed compounds were located within the applicability domain of the model, supporting the reliability of the predictions. To further evaluate their inhibitory potential, molecular docking studies were performed to investigate the interactions between the designed compounds and the α-glucosidase active site. The docking results revealed favorable binding interactions comparable to those reported for known α-glucosidase inhibitors. Furthermore, ADMET analysis indicated generally favorable pharmacokinetic properties, although potential CYP3A4 inhibition-related pharmacokinetic risks were identified and discussed. Molecular dynamics simulations, including replicated runs and MM/GBSA binding free energy calculations, confirmed the stability of the most promising protein–ligand complexes throughout the simulation period. In conclusion, this study proposes a robust and integrated computational workflow combining descriptor generation, QSAR modeling, applicability domain analysis, molecular docking, ADMET prediction, and molecular dynamics simulations for the rational design of potential α-glucosidase inhibitors. The findings highlight the therapeutic potential of the designed derivatives and provide a valuable in silico framework for the future development of antidiabetic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycoside Hydrolase InhibitorsMolecular Docking SimulationPyrimidinesalpha-GlucosidasesDrug DesignQuantitative Structure-Activity RelationshipMolecular Dynamics SimulationHumansComputer SimulationCatalytic Domain

Stichwörter der Autor:innen

2D-QSARADMETalpha-glucosidasediabetesdynamicsmolecular docking

Substanzen

Glycoside Hydrolase InhibitorsPyrimidinesalpha-Glucosidases

Autor:innen und Institutionen

  • Laboratory of Analytical and Molecular Chemistry, Hassan II University of Casablanca, Casablanca 20360, Morocco.
  • Bioorganic Chemistry Team, Faculty of Science, Chouaïb Doukkali University, P.O. Box 24, El Jadida 24000, Morocco.
  • Laboratory of Advanced Materials and Applications (LM2A), Faculty of Sciences Dhar El Mahraz, Sidi Mohamed Ben Abdellah University, Fez 30000, Morocco.
  • Department of Chemistry, College of Science, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.

ORCID-Profile: Oussama Abchir, Bouchra Es-Sounni, Rodouan Touti, Imane Yamari, Abdelouahid Samadi, Samir Chtita

Förderung

  • University of Sharjah
  • United Arab Emirates University
  • Zayed Bin Sultan Center for Health Sciences and UAEU—University of Sharjah

Zitieren

APA

Abchir, O., Rossafi, B., Bouribab, A., Es-Sounni, B., Touti, R., Yamari, I., Samadi, A., & Chtita, S. (2026). In Silico Design of Pyrimidine Derivatives as Potential α-Glucosidase Inhibitors: QSAR, Molecular Docking, ADMET, and Molecular Dynamics Studies. International Journal of Molecular Sciences, 27(13), 5696. https://doi.org/10.3390/ijms27135696

Vancouver

Abchir O, Rossafi B, Bouribab A, Es-Sounni B, Touti R, Yamari I, et al. In Silico Design of Pyrimidine Derivatives as Potential α-Glucosidase Inhibitors: QSAR, Molecular Docking, ADMET, and Molecular Dynamics Studies. International Journal of Molecular Sciences. 2026;27(13):5696. doi:10.3390/ijms27135696

BibTeX
@article{Abchir2026,
  author = {Abchir, Oussama and Rossafi, Bouchra and Bouribab, Amal and Es-Sounni, Bouchra and Touti, Rodouan and Yamari, Imane and Samadi, Abdelouahid and Chtita, Samir},
  title = {In Silico Design of Pyrimidine Derivatives as Potential α-Glucosidase Inhibitors: QSAR, Molecular Docking, ADMET, and Molecular Dynamics Studies},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {13},
  pages = {5696},
  doi = {10.3390/ijms27135696}
}
Kostenlos starten →